A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy - Concepedia

Concepedia

Publication | Open Access

A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy

DOI Full Paper Access

33

Citations

15

References

2002

Year

Jalid Sehouli, Dirk Stengel, G. Oskay, Oumar Camara, Hans-Joachim Hindenburg, Peter Klare, Jens‐Uwe Blohmer, G. Heinrich, Dirk Elling, P. Ledwon,

Annals of Oncology

MedicineMetronomic TherapyGynecologyPhase Ii StudyRelapsed Ovarian CancerCancer TreatmentFirst-line ChemotherapyOncologyRadiation OncologyGynecology OncologyOvarian Cancer

References

	Year	Citations

Page 1

Page 1